Sign in
CompletedNo phase

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)

Key facts

Who runs it
The University of Queensland
Where
Australia and France3 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
300 people enrolled
Started
3 May 2023
Ended
3 Jun 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Chlorhexidine gluconate impregnated bordered polyurethane dressing
  • Standard bordered polyurethane dressing
Record updated
20 May 2026

Who can take part

Age
6 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • PIVC to be inserted with expected dwell >48 hours
  • Provided written and informed consent (patient or carer); Australia only
  • ≥6 years of age (due to size of dressing); France only
  • ≥18 years of age

Who cannot take part

  • Predictably difficult vascular access (IV drug addiction, obesity)
  • Known allergy to CHG or transparent dressing adhesives
  • Burned, non-intact or scarred skin at the insertion site
  • Palliative care patients on end-of-life pathway
  • Patient who has already participated in the study
  • Placement of a PIVC in an emergency, that does not allow the usual rules of hygiene for insertion to be adhered to; Additional exclusions to Australian study only
  • Non-English-speaking patients without interpreter
  • Under the care of Child and Family Services and unable to gain consent from case worker (paediatric patients); Additional exclusions to French study only
  • Patients not benefiting from the French Social Security scheme or not benefiting from it through a third party,
  • Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection
  • Known pregnant or breastfeeding women

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare a chlorhexidine impregnated dressing for peripheral intravenous catheters (PIVCs) to the standard dressing currently used in general medical and surgical inpatient wards.

Read full original descriptionShow less

The main questions it aims to answer are:

* Study Feasibility * Occurrence of infectious complications related to the PIVC

Participants will be randomly allocated to receive either of the below dressings to cover and secure their PIVC:

* The standard dressing used at their hospital, or * The intervention dressing which has Chlorhexidine gluconate (CHG) on it

Researchers will compare standard and CHG dressings to see if the presence of CHG improves the occurrence of infectious complications related to the PIVC.

The 2 groups in the trial

  • ControlExisting treatment, for comparison

    Bordered Polyurethane Dressing

    Treatment: Standard bordered polyurethane dressing

  • InterventionTreatment being tested

    CHG Bordered Polyurethane Dressing

    Treatment: Chlorhexidine gluconate impregnated bordered polyurethane dressing

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Protect PIVCs: An Adaptive Randomized Controlled Trial of a Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs).
Record updated
20 May 2026